Autoimmune Disease Diagnosis Market

Siemens AG (Germany) and Abbott (US) are the Leading Player in the Autoimmune Disease Diagnosis Market

The global autoimmune disease diagnosis market size is expected to reach USD 6.3 billion by 2025 from USD 4.1 billion in 2020, at a CAGR of 8.9%. The growth in this market is driven by the high incidence of autoimmune diseases, increasing awareness about autoimmune diseases, and the growth in research on autoimmune diseases.

The prominent players operating in the global autoimmune disease diagnosis market include Thermo Fisher Scientific (US), Siemens (Germany), Abbott (US), Danaher (US), Bio-Rad Laboratories (US), Grifols (Spain), Trinity Biotech (Ireland), Werfen (Spain), HYCOR Biomedical (US), EUROIMMUN AG (Germany), Oncimmune (UK), HTG Molecular Diagnostics (US), Seramun Diagnostica GmbH (Germany), Exagen Inc. (US), Cambridge Life Sciences Limited (UK), A. Menarini Diagnostics s.r.l (Italy), ORGENTEC Diagnostika (Germany), KRONUS (US), and AESKU GROUP GMBH & CO. KG (Germany).

The players in this market are mainly focused on product launches/approvals, expansion, collaborations, partnerships, and acquisitions to develop and expand their market presence between 2017 and 2020.

To know about the assumptions considered for the study download the pdf brochure 

Siemens AG

Siemens AG (Germany) is among the leaders in the global autoimmune disease diagnosis market in 2018. The company offers its products in the healthcare industry through its business segment of diagnostics, under the Siemens Healthineers. The company is focused primarily on inorganic and organic strategies such as expansion and product launches/approvals. For instance, during December 2018, Siemens expanded its manufacturing unit situated in the Walpole, Mass, United States. The new facility manufactures tests for the immunoassay module of the Atellica Solution. R&D efforts at the site bring new tests to the in-vitro diagnostics market to help physicians diagnose, monitor, and treat diseases. Such development strengthens the position of the company in the market.

Abbott

Abbott (US) is another leading player in the autoimmune disease diagnosis market. The company recorded positive growth in its revenue in 2018, as compared to that of 2017. Moreover, in 2018, the company generated 35% of its total revenue from the United States. The company focuses on organic and inorganic growth, such as collaboration, and product launches/product approval, to strengthen its position in the market. For instance, in 2017, the company entered into a partnership with North West London Pathology for the supply of analytical equipment and consumables, including Abbotts Alinity ci and Alinity h series diagnostics instruments.

Related Reports:

Autoimmune Disease Diagnosis Market by Product (Consumables, Assay Kits, Instruments), Test Type (Inflammatory Markers, Routine Laboratory Tests), Disease (RA, SLE, Thyroiditis, Scleroderma), End User (Hospitals, Clinical Labs) – Global Forecast to 2025

Contact:
Mr. Sanjay Gupta
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]

Autoimmune Disease Diagnosis Market Size,  Share & Growth Report
Report Code
MD 5936
RI Published ON
4/8/2020
Choose License Type
BUY NOW
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

SEND ME A FREE SAMPLE
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2022 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status